Published in Obesity and Diabetes Week, June 26th, 2006
Study 1: Gatifloxacin induces insulin and epinephrine secretion differently in normal and diabetic rats.
In a recently published study, investigators in Japan conducted a study "to clarify the mechanisms of gatifloxacin (GFLX)-induced hypoglycemia and hyperglycemia, the effect of GFLX on serum glucose levels was investigated in normal and diabetic rats. Rats received an intravenous injection of GFLX and their arterial blood was sampled periodically."
Y. Ishiwata and colleagues at Tokyo Medical and Dental University explained, "Diabetic rats were produced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.